Next Article in Journal
Establishing Best Practices for Clinical GWAS: Tackling Imputation and Data Quality Challenges
Previous Article in Journal
Transcription Factors and Methods for the Pharmacological Correction of Their Activity
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
IJMS
Volume 26
Issue 13
10.3390/ijms26136396
ijms-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles
Retraction of Int. J. Mol. Sci. 2020, 21(18), 6664.
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Retraction

RETRACTED: Maiti et al. Ameliorative Properties of Boronic Compounds in In Vitro and In Vivo Models of Alzheimer’s Disease. Int. J. Mol. Sci. 2020, 21, 6664

by
Panchanan Maiti
1,2,3,4,5,*,
Jayeeta Manna
4,
Zoe N. Burch
6,
Denise B. Flaherty
6,
Joseph D. Larkin
7 and
Gary L. Dunbar
1,2,3,4,*
1
Field Neurosciences Institute Laboratory for Restorative Neurology, Central Michigan University, Mt. Pleasant, MI 48859, USA
2
Department of Psychology, Central Michigan University, Mt. Pleasant, MI 48859, USA
3
Program in Neuroscience, Central Michigan University, Mt. Pleasant, MI 48859, USA
4
Field Neurosciences Institute, Ascension St. Mary, Saginaw, MI 48604, USA
5
College of Health and Human Services, Saginaw Valley State University, Saginaw, MI 48604, USA
6
Department of Biology, Eckerd College, St. Petersburg, FL 33711, USA
7
Department of Chemistry, Eckerd College, St. Petersburg, FL 33711, USA
*
Authors to whom correspondence should be addressed.
Int. J. Mol. Sci. 2025, 26(13), 6396; https://doi.org/10.3390/ijms26136396
Submission received: 7 February 2025 / Accepted: 14 February 2025 / Published: 3 July 2025
(This article belongs to the Section Molecular Neurobiology)
Versions Notes
The journal retracts the article titled “Ameliorative Properties of Boronic Compounds in In Vitro and In Vivo Models of Alzheimer’s Disease” [1], cited above.
Following publication, concerns were brought to the attention of the Editorial Office regarding a range of image irregularities contained within this article [1].
Adhering to our complaints procedure, the Editorial Office and Editorial Board conducted an investigation that confirmed a partial overlap of sub-images in Figures 4A, 5A, and 6A showing different experimental conditions, as well as the overlap between a sub-image in Figure 3A in publication [1] and a sub-image in Figure 3 from a different publication [2]. While the authors fully cooperated with the Editorial Office, they were not able to satisfactorily explain the presence of the above-mentioned irregularities. Consequently, the Editorial Board and the authors decided to retract this publication [1], as per MDPI’s retraction policy (https://www.mdpi.com/ethics#_bookmark30).
This retraction was approved by the Editor-in-Chief of the International Journal of Molecular Sciences journal.
Gary L. Dunbar, Denise B. Flaherty and Joseph D. Larkin agreed to this retraction. The remaining authors did not provide a comment on this decision.

References

  1. Maiti, P.; Manna, J.; Burch, Z.N.; Flaherty, D.B.; Larkin, J.D.; Dunbar, G.L. RETRACTED: Ameliorative Properties of Boronic Compounds in In Vitro and In Vivo Models of Alzheimer’s Disease. Int. J. Mol. Sci. 2020, 21, 6664. [Google Scholar] [CrossRef] [PubMed]
  2. Maiti, P.; Bowers, Z.; Bourcier-Schultz, A.; Morse, J.; Dunbar, G.L. Preservation of dendritic spine morphology and postsynaptic signaling markers after treatment with solid lipid curcumin particles in the 5xFAD mouse model of Alzheimer’s amyloidosis. Alzheimers Res. Ther. 2021, 13, 37. [Google Scholar] [CrossRef] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Maiti, P.; Manna, J.; Burch, Z.N.; Flaherty, D.B.; Larkin, J.D.; Dunbar, G.L. RETRACTED: Maiti et al. Ameliorative Properties of Boronic Compounds in In Vitro and In Vivo Models of Alzheimer’s Disease. Int. J. Mol. Sci. 2020, 21, 6664. Int. J. Mol. Sci. 2025, 26, 6396. https://doi.org/10.3390/ijms26136396

AMA Style

Maiti P, Manna J, Burch ZN, Flaherty DB, Larkin JD, Dunbar GL. RETRACTED: Maiti et al. Ameliorative Properties of Boronic Compounds in In Vitro and In Vivo Models of Alzheimer’s Disease. Int. J. Mol. Sci. 2020, 21, 6664. International Journal of Molecular Sciences. 2025; 26(13):6396. https://doi.org/10.3390/ijms26136396

Chicago/Turabian Style

Maiti, Panchanan, Jayeeta Manna, Zoe N. Burch, Denise B. Flaherty, Joseph D. Larkin, and Gary L. Dunbar. 2025. "RETRACTED: Maiti et al. Ameliorative Properties of Boronic Compounds in In Vitro and In Vivo Models of Alzheimer’s Disease. Int. J. Mol. Sci. 2020, 21, 6664" International Journal of Molecular Sciences 26, no. 13: 6396. https://doi.org/10.3390/ijms26136396

APA Style

Maiti, P., Manna, J., Burch, Z. N., Flaherty, D. B., Larkin, J. D., & Dunbar, G. L. (2025). RETRACTED: Maiti et al. Ameliorative Properties of Boronic Compounds in In Vitro and In Vivo Models of Alzheimer’s Disease. Int. J. Mol. Sci. 2020, 21, 6664. International Journal of Molecular Sciences, 26(13), 6396. https://doi.org/10.3390/ijms26136396

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop